Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mustafa Balcioglu

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Chemical Communications (Cambridge, England)|February 4, 2016
Reprogrammable multiplexed detection of circulating oncomiRs using hybridization chain reactionMuhit Rana, Mustafa Balcioglu, Maya Kovach, et al.
Bioconjugate Chemistry|March 4, 2015
Monitoring the multitask mechanism of DNase I activity using graphene nanoassembliesNeil M Robertson, Mustafa Salih Hizir, Mustafa Balcioglu, et al.
Analytical Chemistry|December 15, 2015
Multiplexed Activity of perAuxidase: DNA-Capped AuNPs Act as Adjustable PeroxidaseMustafa Salih Hizir, Meryem Top, Mustafa Balcioglu, et al.
Biosensors & Bioelectronics|March 6, 2016
Unlocked Nucleic Acids for miRNA detection using two dimensional nano-graphene oxideNeil M Robertson, Amy E Toscano, Vincent E LaMantia, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|August 26, 2015
Discriminating a Single Nucleotide Difference for Enhanced miRNA Detection Using Tunable Graphene and Oligonucleotide NanodevicesNeil M Robertson, Mustafa Salih Hizir, Mustafa Balcioglu, et al.
Frontiers in Oncology|February 21, 2022
Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of RelapseBinod Dhakal, Shruti Sharma, Mustafa Balcioglu, et al.
Nature Cancer|October 17, 2022
A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genesJoshua J Gruber, Anosheh Afghahi, Kirsten Timms, et al.
The Oncologist|July 16, 2024
Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinomaAndres F Correa, Ekaterina Kalashnikova, Hsin-Ta Wu, et al.
JCO Precision Oncology|September 28, 2022
Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease RelapseFrédéric Cailleux, Elisa Agostinetto, Matteo Lambertini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2019
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder CarcinomaEmil Christensen, Karin Birkenkamp-Demtröder, Himanshu Sethi, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Chemical Communications (Cambridge, England)|February 4, 2016
Reprogrammable multiplexed detection of circulating oncomiRs using hybridization chain reactionMuhit Rana, Mustafa Balcioglu, Maya Kovach, et al.
Bioconjugate Chemistry|March 4, 2015
Monitoring the multitask mechanism of DNase I activity using graphene nanoassembliesNeil M Robertson, Mustafa Salih Hizir, Mustafa Balcioglu, et al.
Analytical Chemistry|December 15, 2015
Multiplexed Activity of perAuxidase: DNA-Capped AuNPs Act as Adjustable PeroxidaseMustafa Salih Hizir, Meryem Top, Mustafa Balcioglu, et al.
Biosensors & Bioelectronics|March 6, 2016
Unlocked Nucleic Acids for miRNA detection using two dimensional nano-graphene oxideNeil M Robertson, Amy E Toscano, Vincent E LaMantia, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|August 26, 2015
Discriminating a Single Nucleotide Difference for Enhanced miRNA Detection Using Tunable Graphene and Oligonucleotide NanodevicesNeil M Robertson, Mustafa Salih Hizir, Mustafa Balcioglu, et al.
Frontiers in Oncology|February 21, 2022
Assessment of Molecular Residual Disease Using Circulating Tumor DNA to Identify Multiple Myeloma Patients at High Risk of RelapseBinod Dhakal, Shruti Sharma, Mustafa Balcioglu, et al.
Nature Cancer|October 17, 2022
A phase II study of talazoparib monotherapy in patients with wild-type BRCA1 and BRCA2 with a mutation in other homologous recombination genesJoshua J Gruber, Anosheh Afghahi, Kirsten Timms, et al.
The Oncologist|July 16, 2024
Association of circulating tumor DNA with patient prognosis in surgically resected renal cell carcinomaAndres F Correa, Ekaterina Kalashnikova, Hsin-Ta Wu, et al.
JCO Precision Oncology|September 28, 2022
Circulating Tumor DNA After Neoadjuvant Chemotherapy in Breast Cancer Is Associated With Disease RelapseFrédéric Cailleux, Elisa Agostinetto, Matteo Lambertini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 7, 2019
Early Detection of Metastatic Relapse and Monitoring of Therapeutic Efficacy by Ultra-Deep Sequencing of Plasma Cell-Free DNA in Patients With Urothelial Bladder CarcinomaEmil Christensen, Karin Birkenkamp-Demtröder, Himanshu Sethi, et al.
Pageof 3